MUC4 and neoplasm: Given the distinctive roles of MUC4 in immunomodulation during cancer progression and metastasis (Yang et al., 2020; Peng et al., 2021), we used TIMER2.0 to investigate the impact of the expression of MUC4 on tumor immune infiltration levels.